News & Events

September 8, 2020

BrainsWay to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

CRESSKILL, N.J. and JERUSALEM, Israel, September 8, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

September 2, 2020

BrainsWay Announces Presentations at Upcoming Investor Conferences

CRESSKILL, N.J. and JERUSALEM, Israel, September 2, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

August 24, 2020

BrainsWay Receives FDA Clearance for Smoking Addiction in Adults

Company Intends to Execute a Controlled U.S. Market Release in Early 2021 This is the Company’s third...

August 13, 2020

Wauwatosa, Wisconsin

Network with BrainsWay Providers in Wauwatosa, WI Copy

Dr. Hong Yin of New Frontiers Psychiatry & TMS in Milwaukee, WI will be speaking about her success...

July 25 - July 27, 2020

Las Vegas, Nevada

Meet BrainsWay® Virtually at Psych Congress – Elevate

BrainsWay is participating in Elevate by Psych Congress Virtual Experience through July 25 -27. The conference...

July 31 - August 2, 2020

Seattle, Washington

Meet BrainsWay® Virtually at the Annual IOCDF Conference

BrainsWay is participating in the Online OCD Conference through July 31 – August 2. The first event...

In the Media

September 15, 2020

Deep TMS Patient Describes Long Journey to Wellness for

Bre Hushaw walks through her in-depth account of how prior treatments for depression were...

September 6, 2020

Observer Discusses BrainsWay Treatment for MDD with CEO Christopher von Jako

Observer interviews BrainsWay CEO, Dr. Christopher von Jako, discussing the growing mental health crisis...

August 26, 2020

Dr. Mark George Outlines the Clinical Study Underlying BrainsWay Treatment of Smoking Addiction

Professor Mark George of the Medical University of South Carolina describes the clinical data behind...